BRASARTAN CTDN

This brand name is authorized in Ecuador

Active ingredients

The drug BRASARTAN CTDN contains a combination of these active pharmaceutical ingredients (APIs):

1 Valsartan
UNII 80M03YXJ7I - VALSARTAN

Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II.

Read about Valsartan
2 Chlortalidone
UNII Q0MQD1073Q - CHLORTHALIDONE

Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action.

Read about Chlortalidone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C09DA03 Valsartan and diuretics C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 2052-MEE-0416, 2404-MEE-0816, 2453-MEE-0916

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.